PT Multi Medika Internasional Tbk (IDX:MMIX)
226.00
+12.00 (5.61%)
At close: Dec 5, 2025
IDX:MMIX Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 236,798 | 191,991 | 175,134 | 175,094 | 181,842 | 5,931 |
| Revenue Growth (YoY) | 84.29% | 9.63% | 0.02% | -3.71% | 2965.83% | - |
| Cost of Revenue | 99,705 | 81,686 | 71,832 | 84,014 | 114,249 | 4,006 |
| Gross Profit | 137,093 | 110,305 | 103,302 | 91,080 | 67,593 | 1,926 |
| Selling, General & Admin | 87,091 | 90,276 | 75,182 | 58,832 | 31,226 | 478.16 |
| Other Operating Expenses | 624.77 | 618.53 | 2,642 | 948.51 | 2,934 | 6.57 |
| Operating Expenses | 87,716 | 90,895 | 77,824 | 59,780 | 34,160 | 484.73 |
| Operating Income | 49,376 | 19,410 | 25,479 | 31,300 | 33,433 | 1,441 |
| Interest Expense | -1,286 | -2,897 | -1,293 | -678.56 | -883.14 | -0.07 |
| Interest & Investment Income | 206.43 | 740.76 | 130.79 | 84.68 | 18.33 | 0.37 |
| Currency Exchange Gain (Loss) | 86.37 | 50 | 37.74 | - | 4.2 | - |
| Other Non Operating Income (Expenses) | -24,319 | -15,524 | -2,826 | -200.11 | -360 | - |
| Pretax Income | 24,064 | 1,779 | 21,528 | 30,506 | 32,213 | 1,441 |
| Income Tax Expense | 2,174 | 572.53 | 5,015 | 6,838 | 7,168 | 29.67 |
| Net Income | 21,890 | 1,207 | 16,513 | 23,668 | 25,045 | 1,412 |
| Net Income to Common | 21,890 | 1,207 | 16,513 | 23,668 | 25,045 | 1,412 |
| Net Income Growth | - | -92.69% | -30.23% | -5.50% | 1674.33% | - |
| Shares Outstanding (Basic) | 4,801 | 4,800 | 3,456 | 4,001 | 3,280 | - |
| Shares Outstanding (Diluted) | 4,801 | 4,800 | 3,456 | 4,001 | 3,280 | - |
| Shares Change (YoY) | 18.41% | 38.90% | -13.62% | 21.98% | - | - |
| EPS (Basic) | 4.56 | 0.25 | 4.78 | 5.92 | 7.64 | - |
| EPS (Diluted) | 4.56 | 0.25 | 4.78 | 5.92 | 7.64 | - |
| EPS Growth | - | -94.74% | -19.23% | -22.53% | - | - |
| Free Cash Flow | 9,436 | -122,593 | -110,023 | -41,549 | 4,708 | -2,528 |
| Free Cash Flow Per Share | 1.97 | -25.54 | -31.84 | -10.38 | 1.44 | - |
| Gross Margin | 57.89% | 57.45% | 58.98% | 52.02% | 37.17% | 32.46% |
| Operating Margin | 20.85% | 10.11% | 14.55% | 17.88% | 18.39% | 24.29% |
| Profit Margin | 9.24% | 0.63% | 9.43% | 13.52% | 13.77% | 23.80% |
| Free Cash Flow Margin | 3.98% | -63.85% | -62.82% | -23.73% | 2.59% | -42.62% |
| EBITDA | 56,711 | 26,549 | 29,320 | 32,081 | 33,571 | - |
| EBITDA Margin | 23.95% | 13.83% | 16.74% | 18.32% | 18.46% | - |
| D&A For EBITDA | 7,335 | 7,139 | 3,841 | 780.69 | 138.03 | - |
| EBIT | 49,376 | 19,410 | 25,479 | 31,300 | 33,433 | 1,441 |
| EBIT Margin | 20.85% | 10.11% | 14.55% | 17.88% | 18.39% | 24.29% |
| Effective Tax Rate | 9.03% | 32.17% | 23.30% | 22.41% | 22.25% | 2.06% |
| Advertising Expenses | - | 22,246 | 25,601 | 28,176 | 8,517 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.